Sort   by:  
 Page size 
UnknownA novel lipid metabolism-based risk model associated with immunosuppressive mechanisms in diffuse large B-cell lymphoma.
Not available
S-EPMC10801940 | biostudies-literature
UnknownSmall bone marrow adipocytes predict poor prognosis in acute myeloid leukemia.
Not available
S-EPMC5777209 | biostudies-literature
UnknownEtesevimab in combination with JS026 neutralizing SARS-CoV-2 and its variants.
Not available
S-EPMC8843163 | biostudies-literature
UnknownPreclinical investigations and a first-in-human phase 1a trial of JS007, a novel anti-CTLA-4 antibody, in patients with advanced solid tumors.
Not available
S-EPMC11443874 | biostudies-literature
UnknownGrowth differentiation factor 15 contributes to marrow adipocyte remodeling in response to the growth of leukemic cells.
Not available
S-EPMC5863796 | biostudies-literature
UnknownA CD36-dependent non-canonical lipid metabolism program promotes immune escape and resistance to hypomethylating agent therapy in AML.
Not available
S-EPMC11228649 | biostudies-literature
UnknownToripalimab Plus Chemotherapy for Recurrent or Metastatic Nasopharyngeal Carcinoma: The JUPITER-02 Randomized Clinical Trial.
Not available
S-EPMC10685882 | biostudies-literature
UnknownPerioperative Toripalimab Plus Chemotherapy for Patients With Resectable Non-Small Cell Lung Cancer: The Neotorch Randomized Clinical Trial.
Not available
S-EPMC10792477 | biostudies-literature
Sort   by:  
 Page size